BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 12404946)

  • 41. [Hormone replacement treatment and breast cancer].
    Comino Delgado R; Fernández-Alba JJ
    An R Acad Nac Med (Madr); 1999; 116(3):557-603. PubMed ID: 10846581
    [No Abstract]   [Full Text] [Related]  

  • 42. [Hormone replacement therapy in menopause and risk of breast cancer].
    Fournier A; Hill C; Clavel-Chapelon F
    Bull Cancer; 2003 Oct; 90(10):821-31. PubMed ID: 14706912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Menopausal estrogen therapy and risk of breast cancer].
    Olsen J
    Ugeskr Laeger; 1992 Oct; 154(41):2840. PubMed ID: 1413229
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hormone replacement therapy of menopause. When to begin? When to stop?].
    Tabaste JL
    Contracept Fertil Sex; 1997 Apr; 25(4):285-7. PubMed ID: 9229518
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same].
    Ribot C; Trémollieres F
    Gynecol Obstet Fertil; 2007 May; 35(5):388-97. PubMed ID: 17392010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hormone replacement therapy in postmenopausal women: all the treatments are not the same. Do all the patients have the same characteristics?].
    Mathelin C; Brettes JP
    Gynecol Obstet Fertil; 2007 Jun; 35(6):502-3. PubMed ID: 17543563
    [No Abstract]   [Full Text] [Related]  

  • 47. Commentary: Hormone therapy and breast cancer incidence: did epidemiologists miss an effect on national trends?
    Paul C
    Int J Epidemiol; 2008 Jun; 37(3):638-40. PubMed ID: 18375444
    [No Abstract]   [Full Text] [Related]  

  • 48. [Progesterone and breast cancer].
    Mansueto G; Mistretta V; Angeletti F; Trento LK; Angelozzi D; Bracaglia M; Pagliarella MR; Di Muccio L
    Recenti Prog Med; 2006; 97(7-8):376-80. PubMed ID: 16913172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pros and cons. Hormone therapy can do wonders for women, but a new cancer study underscores the risks.
    Nash JM
    Time; 2000 Feb; 155(5):68-9. PubMed ID: 10787970
    [No Abstract]   [Full Text] [Related]  

  • 50. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors.
    Holmberg L; Iversen OE; Rudenstam CM; Hammar M; Kumpulainen E; Jaskiewicz J; Jassem J; Dobaczewska D; Fjosne HE; Peralta O; Arriagada R; Holmqvist M; Maenpaa J;
    J Natl Cancer Inst; 2008 Apr; 100(7):475-82. PubMed ID: 18364505
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Re: Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
    Eisinger F; Huiart L
    J Natl Cancer Inst; 2009 Feb; 101(4):277; author reply 277-8. PubMed ID: 19211447
    [No Abstract]   [Full Text] [Related]  

  • 52. [The breast cancer risk in postmenopausal estrogen substitution. The dilemma of risk assessment].
    Lippert TH; Mück AO
    Dtsch Med Wochenschr; 1997 Jul; 122(28-29):908-11. PubMed ID: 9264923
    [No Abstract]   [Full Text] [Related]  

  • 53. Postmenopausal hormone therapy and the risk of breast cancer. A clinician's view.
    Speroff L
    Maturitas; 2004 Sep; 49(1):51-7. PubMed ID: 15351096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Do risks of hormone therapy persist after discontinuation?
    J Fam Pract; 2008 Jun; 57(6):366, 369. PubMed ID: 18677802
    [No Abstract]   [Full Text] [Related]  

  • 55. WHI and breast cancer: a response to a recent publication from the WHI.
    Pines A; Sturdee DW; Birkhäuser M;
    Climacteric; 2006 Aug; 9(4):244. PubMed ID: 16857654
    [No Abstract]   [Full Text] [Related]  

  • 56. Breast cancer cases decline; may be tied to drop in hormone use.
    Mayo Clin Womens Healthsource; 2007 May; 11(5):3. PubMed ID: 17476172
    [No Abstract]   [Full Text] [Related]  

  • 57. Hormone replacement and the risk of breast cancer in Turner's syndrome.
    Bösze P; Tóth A; Török M
    N Engl J Med; 2006 Dec; 355(24):2599-600. PubMed ID: 17167149
    [No Abstract]   [Full Text] [Related]  

  • 58. Breast cancer risk in postmenopausal women using estrogen-only therapy.
    Lyytinen H; Pukkala E; Ylikorkala O
    Obstet Gynecol; 2006 Dec; 108(6):1354-60. PubMed ID: 17138766
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Breast cancer risk with hormone replacement therapy. A matter of interpretation].
    Röhm W
    MMW Fortschr Med; 2004 Feb; 146(6):15; author reply 15. PubMed ID: 15035307
    [No Abstract]   [Full Text] [Related]  

  • 60. Breast cancer and hormone-replacement therapy.
    Brunoski T
    N Engl J Med; 1995 Nov; 333(20):1355; author reply 1357-8. PubMed ID: 7566032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.